<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>US Sales of Zantec Tumbled 55%</title><link>http://articles.mercola.com/sites/articles/archive/2008/01/02/zantac.aspx</link><description>US sales of former best-selling ulcer treatment ranitidine (Zantac) fell by 55% Zantac, which was the world's biggest-selling drug for 11 years until last year, currently faces eight generic competitors in the key US market. According to market research</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>